Unicycive Therapeutics has filed a notice of an exempt offering of securities to raise $50 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Unicycive Therapeutics is raising up to $50,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shalabh Gupta played a…
